Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  ANTA PHAR       

 SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2016 2,00 M
EBIT 2016 -53,0 M
Net income 2016 -53,1 M
Debt 2016 -
Yield 2016 -
Sales 2017 0,38 M
EBIT 2017 -61,3 M
Net income 2017 -56,5 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales 2016 65,9x
Capi. / Sales 2017 352x
Capitalization 132 M
More Financials
Company
Anthera Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on developing and commercializing products to treat treat serious and life-threatening diseases, including lupus, lupus with glomerulonephritis, IgA nephropathy, and exocrine pancreatic insufficiency due to cystic... 
More about the company
Surperformance© ratings of ANTA PHAR
Trading Rating : Investor Rating :
More Ratings
Latest news on ANTA PHAR
04/30 ANTHERA PHARMACEUTICALS INC : Entry into a Material Definitive Agreement, Change..
04/28 ANTHERA PHARMACEUTICALS : Greenphire Empowers Orphan Drug and Rare Disease Clini..
04/27 Anthera Pharmaceuticals Appoints Brent Furse to Board of Directors
04/27 MEDICINES : Anthera Pharmaceuticals Appoints Brent Furse to Board of Directors
04/22 ANTHERA PHARMACEUTICALS INC : Entry into a Material Definitive Agreement, Termin..
03/10 ANTHERA PHARMACEUTICALS : Results of Operations and Financial Condition, Financi..
03/10 ANTHERA PHARMACEUTICALS : reports 4Q loss
03/10 Anthera Pharmaceuticals Provides Business Update and Reports 2015 Fourth Quar..
More news
Sector news : Bio Therapeutic Drugs
10:14p MEDIVATION : Reports First Quarter 2016 Financial Results
08:27pDJSANOFI : Will Try to Oust Medivation Board Unless Deal Talks Start -- Update
07:38pDJREGENERON PHARMACEUTICALS : Raises Sales Expectations for Eylea -- Update
More sector news : Bio Therapeutic Drugs
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions